← back to search

William Clark

University of Glasgow · GB
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Biology, Cancer research, Cell biology, Genetics, Immunotherapy, and CXC chemokine receptors.
h-index
citations
1,346
works
12
NIH funding
primary concept
email

Recent publications

Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes
EMBO Reports 2025cited by 8position: middledoi
Inflammatory markers and body mass index amoung hispanic children
PLoS ONE 2024cited by 5position: middledoi
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target
Nature Metabolism 2023cited by 56position: middledoi
CXCR2 inhibition enables NASH-HCC immunotherapy
Gut 2022cited by 223position: middledoi
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
Nature Communications 2022cited by 15position: middledoi
CXCR2 inhibition enables NASH-HCC immunotherapy
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 3position: middledoi
NOTUM from Apc-mutant cells biases clonal competition to initiate cancer
Nature 2021cited by 249position: middledoi
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis
Nature Communications 2021cited by 79position: middledoi
CTRP3 and serum triglycerides in children aged 7-10 years
PLoS ONE 2020cited by 10position: middledoi
TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence
Science Translational Medicine 2018cited by 259position: middledoi
Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function
Molecular Cell 2017cited by 240position: middledoi
Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions
Genome biology 2017cited by 199position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Arsham Alamian · University of Miami2 papers (2020–2024) · 2 papers (2020–2024)Scott W. Lowe · Memorial Sloan Kettering Cancer Center1 papers (2017–2017)Richard R. Meehan · University of Edinburgh1 papers (2017–2017) · 1 papers (2024–2024)Colin Nixon · Cancer Research UK1 papers (2017–2017)Kevin M. Ryan · Knexus Research (United States)1 papers (2017–2017) · 1 papers (2017–2017)Simon Wilkinson · University of Edinburgh1 papers (2017–2017)John P. Thomson · University of Edinburgh1 papers (2017–2017)Mohammed Rather · University of Glasgow1 papers (2017–2017)Nilgun Tasdemir · University of Pittsburgh1 papers (2017–2017) · 1 papers (2024–2024) · 1 papers (2017–2017)Richard A. Miller · Wake Forest University1 papers (2017–2017)Ann Hedley · University of Glasgow1 papers (2017–2017)T. Andrew Joyner · Medical University of South Carolina1 papers (2024–2024)Ivan Đikić · Goethe University Frankfurt1 papers (2017–2017)Duncan Sproul · Edinburgh Cancer Research1 papers (2017–2017) · 1 papers (2017–2017)